RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System
RenovoRx, a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, a novel, FDA-cleared delivery platform, today announced that it has received its first purchase orders for RenovoCath devices.